During Tuesday’s Morning trade, Shares of Biogen Inc (NASDAQ:BIIB), gained 1.53% to $308.43.
Biogen Inc. declared it will report fourth quarter and year end 2015 financial results on Wednesday, January 27, 2016, before the financial markets open.
Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It provides AVONEX to treat relapsing multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Crohns disease; PLEGRIDY to treat relapsing MS; TECFIDERA to treat MS; FAMPYRA to improve walking in adult patients with MS; ALPROLIX to treat hemophilia B; ELOCTATE to treat hemophilia A; RITUXAN for treating non-Hodgkin’s lymphoma, rheumatoid arthritis, and chronic lymphocytic leukemia (CLL), in addition to two forms of ANCA-associated vasculitis; GAZYVA for the treatment of patients with formerly untreated CLL; and FUMADERM to treat severe plaque psoriasis in adult patients.
Shares of Omnicom Group Inc. (NYSE:OMC), inclined 0.34% to $76.77, during its current trading session.
COLANGELO, part of the DAS Group of Companies, declared the appointment of John Minnec to President. Minnec, a global marketing and advertising executive and recognized evangelist for brand innovation, joined the agency in June and has already had a meaningful impact within the organization, and with its clients and partners.
As General Manager of COLANGELO, Minnec has assisted lead the restructuring of the agency into three verticals – Luxury; Lifestyle; Home, Health & Wellness – allowing teams to focus on identifying insights that connect with consumers and shoppers, delivering even greater results for clients. As President, Minnec’s focus will be to continue to amplify the agency’s distinct offering, the Unfair Advantage™ brand transformation model while leveraging his expertise to further evolve the firm’s Shopper and Digital practices.
“The talented individuals at COLANGELO have built a powerful agency that delivers clients more than their share of brand growth, and since joining COLANGELO in June, I have had the pleasure of being part of an organization that is delivering game-changing ideas, and excellence in brand innovation and creativity,” said Minnec. “I look forward to building on the success that has brought the agency to this point.”
Omnicom Group Inc., together with its auxiliaries, operates as an advertising, marketing, and corporate communications services company in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It offers services in advertising, customer relationship administration, public relations, and specialty communications areas.
Finally, The Carlyle Group LP (NASDAQ:CG), lost -0.06%, and is now trading at $15.86.
Symantec Corp. (SYMC) and The Carlyle Group (CG), declared that they expect to close Carlyle’s acquisition of Veritas on January 29, 2016, subject to the satisfaction of customary closing conditions. The closing was formerly predictable to take place on January 1, 2016.
Bill Coleman, who will become CEO of Veritas upon the close of the transaction, said, “The team at Carlyle and I continue to be very excited about Veritas, its strong brand and products, in addition to its top-tier customer and partner base. We see in Veritas an incredible opportunity for value creation and look forward to working alongside the strong existing Veritas team.”
The Carlyle Group LP is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in administration-led/ Leveraged buyouts, privatizations, divestitures, planned minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which comprise Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
